BioShield Law Deflects Devices With Commercial Opportunity – Aethlon CEO
This article was originally published in The Gray Sheet
Executive Summary
BioShield requirements related to stockpile purchases of medical countermeasures should be made less restrictive, according to Aethlon Medical CEO James Joyce